Dishman Carbogen Amcis Limited (BOM:540701)
India · Delayed Price · Currency is INR 153.35
+2.20 (1.46%)
At close: Oct 6, 2026
Dishman Carbogen Amcis Employees
Dishman Carbogen Amcis had 934 employees as of March 31, 2026. The number of employees decreased by 172 or -15.55% compared to the previous year.
Employees
934
Change (1Y)
-172
Growth (1Y)
-15.55%
Revenue / Employee
31.07M INR
Profits / Employee
173.02K INR
Market Cap
23.90B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 934 | -172 | -15.55% |
| Mar 31, 2025 | 1,106 | -26 | -2.30% |
| Mar 31, 2024 | 1,132 | -163 | -12.59% |
| Mar 31, 2023 | 1,295 | 127 | 10.87% |
| Mar 31, 2022 | 1,168 | 239 | 25.73% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IOL Chemicals and Pharmaceuticals | 3,095 |
| Symbiotec Pharmalab | 1,915 |
| Shilpa Medicare | 1,241 |
| Bajaj HealthCare | 949 |
| NGL Fine-Chem | 498 |
| Influx Healthtech | 278 |
| Shree Ganesh Remedies | 224 |
| Gujarat Themis Biosyn | 221 |
Dishman Carbogen Amcis News
- 3 months ago - Dishman Carbogen Amcis shares rise nearly 3% on June 30 after Swiss subsidiary commissions 1.2 MW solar power plant; here's why - Business Upturn
- 1 year ago - Dishman Carbogen clears US FDA inspection at Naroda facility with no observations - Business Upturn
- 1 year ago - Dishman Carbogen shares in focus after Swiss subsidiary signs CHF 25 million co-investment agreement - Business Upturn
- 1 year ago - Dishman Carbogen Amcis shares surge over 11% as company swings to profit in Q4, EBITDA margin doubles - Business Upturn
- 1 year ago - Dishman Carbogen shares surge 5% after arm gets drug manufacturing licence In China - Business Upturn
- 1 year ago - Dishman Carbogen Amcis subsidiary receives drug manufacturing license in China - Business Upturn
- 1 year ago - Dishman Carbogen Amcis shares jump nearly 2% after board approves Rs 50 crore debenture issuance - Business Upturn
- 1 year ago - Dishman Carbogen subsidiary successfully completes Swissmedic inspection of its Vionnaz facility - Business Upturn